Interestingly, despite activation of SRC signalling in ASC tumours, inclusion of sar did not exacerbate cytotoxicity in ASC slices, which deviates from the regression of KL‐driven tumours following dact + sel treatment in combination with the non‐selective SRC inhibitor dasatinib 14. This evidence concerns the gene SRC and neoplasm.